Basic Information
DYMISTA NASAL SPRAY
SPRAY, METERED
Regulatory Information
SIN15255P
June 5, 2017
Prescription Only
Therapeutic
NASAL
August 10, 2023
June 3, 2025
XR01AD58
Company Information
Active Ingredients
Fluticasone propionate
Strength: 0.0365 %w/w
Azelastine hydrochloride
Strength: 0.1 %w/w
Detailed Information
Contraindications
**CONTRAINDICATIONS** Hypersensitivity to the active substance(s) or to any of the excipients.
Indication Information
**INDICATIONS** Symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 6 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.